Hearing Impairment Clinical Presentation

  • Author: Rahul K Shah; Chief Editor: Glenn C Isaacson, MD, FACS, FAAP   more...
 
Updated: Jul 25, 2011
 

History

General presentation and age at detection

Before neonatal hearing screening was routine, deafness was diagnosed at a mean age of 2.5 years. Since the implementation of successful Universal Newborn Hearing Screening (UNHS) programs, this improved to a mean of 14 months, with 74% being diagnosed and receiving intervention by 6 months. Most recently, the average age of diagnosis has been reported to be just 2-3 months.[17] The goal is universal screening, to detect hearing loss prior to 3 months, and intervention prior to 6 months, in accordance with the Newborn and Infant Hearing Loss: Detection and Intervention policy statement from the American Academy of Pediatrics (AAP).[2]

In a screened population, the rate of referral for services before 6 months is 19 times higher than in an unscreened population. The rates for confirmation and management of hearing loss are 5 times and 8 times higher, respectively, for a screened population.

In the unscreened population or for those with progressive or acquired hearing loss, parents are the first to suspect hearing loss in almost two thirds of the patients. Pediatricians detect roughly 10% of cases, and other healthcare providers suspect it first in approximately 15% of patients. The mean time from the first suspicion of hearing loss to its diagnosis is 9 months.

High-risk criteria for hearing loss in neonates and infants

Prior to most states implementing UNHS programs, the high-risk criteria were an important tool in the early detection of hearing loss. However, the dissemination of high-risk criteria for neonates and infants in 1990 did not notably alter the mean age at diagnosis. About 50% of children with SNHL do not meet any of the criteria listed, and only 10% of neonates have 1 or more of the high-risk criteria that prompt an evaluation. These rates were among the reasons cited for the need for universal neonatal hearing screening. However, these criteria (especially for age 29 d to 2 y) serve as a reminder for those children for whom providers should have an increased level of suspicion and a decreased threshold to refer for testing for missed congenital, progressive, or acquired hearing loss.

High-risk criteria for neonates (birth to 28 d) are as follows:

  • Family history of congenital or early SNHL
  • Congenital infection known to be associated with SNHL
  • Craniofacial anomalies
  • Birth weight of more than 1500 g (< 3.3 lb)
  • Hyperbilirubinemia over the exchange level
  • Exposure to ototoxic medications
  • Low Apgar scores at birth
  • Prolonged mechanical ventilation
  • Findings of a syndrome associated with SNHL

High-risk criteria for infants (29 d to 2 y) are as follows:

  • Concern about hearing, speech, language, and/or developmental delay
  • Bacterial meningitis
  • Neonatal risk factors associated with SNHL
  • Head trauma, especially with fracture of the temporal bone
  • Findings of a syndrome associated with SNHL
  • Exposure to ototoxic medications
  • Neurodegenerative disorders
  • Infectious diseases associated with SNHL

Indications for a hearing evaluation and findings

Concern about a child's hearing loss expressed by a parent or caregiver always should prompt immediate evaluation. Hearing loss can be diagnosed at whatever age it is suspected, so delaying the diagnosis in the belief that a child is too young to be tested is unjustified. Other causes of language delay or behavioral problems should be considered as well, but hearing loss may be the cause of these problems. The results of referral for hearing loss are definitive, whereas evaluations for language or behavioral problems are more subjective and dependent on the skill of the person providing the evaluation.

Children with congenital or perinatally acquired profound SNHL (>90 dB) may present with loss of cooing by the age of 6-9 months and with frank language delay. Those with hearing loss less severe than this may present with minor speech impediments, language delay, behavioral problems, or school failure. The degree of hearing loss or loss of speech discrimination correlates with the patient's speech and language problems.

Behavioral problems may be major or minor, and they are probably best correlated with the child's personality and with how the parents deal with what they may consider a stubborn child. Before speech impediments, mental retardation, autism, attention deficit, or adjustment disorders are presumed, many children could benefit from a hearing evaluation.

Upon evaluation, a child who cannot hear normal speech can reproduce only what he or she hears. A child who cannot hear the teacher cannot learn. In addition, a child who is bored fidgets. A child who cannot understand and who is berated by caregivers for lack of cooperation may act out.

Healthcare providers should understand that normal speech volumes are 30-50 dB, whereas typical street traffic is about 60 dB. Standard phones ring and shouts register at approximately 80 dB, and lawnmowers are approximately 90 dB. Therefore, children with a 60-dB hearing loss hear their mother when she yells at them and startle when the telephone rings. However, they do not hear most conversational speech, and they may not always hear the teacher in a classroom, especially if they are not in the front and there is significant extraneous noise.

If children have poor speech discrimination, the diagnosis is usually made relatively early because they may mispronounce words or may be unable to understand what is being said. In children with good speech discrimination, hearing loss may go undetected because speech production and comprehension are less affected.

Children with mild hearing losses that begin prelingually or postlingually may present with difficulties late in childhood.

In general, children who lose their hearing postlingually present with a decline in language skills they had previously achieved. In children of this age group, clinically significant hearing loss is usually the result of an obvious medical event. Those who lose their hearing postlingually may be able to describe their loss. However, if the decline is gradual, they may not initially recognize the deficit.

Worsening speech or school performance may herald long-standing or progressive mild-to-moderate hearing loss. Other presentations of mild or progressive hearing loss may be withdrawal from social activities and playing alone, or playing the television and music with increasingly loud volumes.

Next

Physical

Carefully evaluate children with congenital hearing loss for any evidence of other physical stigmata or for possible associated syndromes (ie, a white forelock to suggest Waardenburg syndrome). For a partial list of syndromes related to deafness, see Causes. Because almost every organ system can potentially provide evidence of an associated syndrome, detailed physical examination is necessary.

For patients with acquired hearing loss an otolaryngologist should evaluate their ears by inspecting them for external defects or for obstructions that block sound conduction down the ear canal (eg, cerumen, foreign bodies). In addition, pneumatic otoscopy should be performed to detect any evidence of current or chronic infections, such as perforation or scarring of the tympanic membrane, cholesteatoma, abnormal landmarks, and fluid behind the tympanic membrane.

The remainder of the otolaryngology examination should be focused on the head and neck to carefully rule out other abnormalities that may lead to a diagnosis.

If children are old enough to cooperate, they should undergo tests of balance because dysfunction of the inner ear or vestibular nerve may also be present.

Previous
Next

Causes

Genetic causes

Most sources cite genetic causes as accounting for at least 50% of hearing loss.[1, 14, 16, 18] These can be divided into syndromic and nonsyndromic types. As with all genetic syndromes, genetic causes of hearing loss may be autosomal dominant (AD), autosomal recessive (AR), X-linked, mitochondrial, or sporadic.

Nonsyndromic deafness accounts for slightly more than two thirds of all cases of genetic deafness. It probably accounts for most cases classified as unknown. Children with nonsyndromic deafness are deaf or hard of hearing; however, they have no other physical abnormalities, no particular risk to other organ systems, and no increased risk of mental deficiency. Some children have a history of deafness in a close or distant family member. Others have new mutations or an AR gene with no known proband. The histories of subsequent siblings and progeny may help to distinguish a genetic cause from developmental arrest or a prenatal insult.

Exciting developments in genetic mapping have revealed approximately 2 dozen abnormal genes that lead to deafness. These genes have been classified according to their mode of inheritance: ADs (DFNA1 through DFNA48), ARs (DFNB1 through DFNB67), X-linked recessives (DFN1 through DFN8), or mitochondrial (at least 5 loci identified, including 12Sr RNA and tRNA-Ser UCN).

Mutations in these genes result in a functional or structural defect (eg, collagen in the basilar membrane; a structural defect in a membrane-gating protein, such as connexin 26).[19] In some of these, one or more specific mutations in the DNA sequence have been identified. One such example is DFNA44, for which the problem is on gene CCDC50, which codes for Ymer, a cytoplasmic protein that inhibits the down-regulation of the epidermal growth factor receptor, affecting the normal development of the structural organization of the pillar cells of the inner ear.[20, 21] Several of the genes exhibit variable penetrance, so the presence of the gene does not correlate directly with the degree of hearing loss.

Syndromic deafness accounts for the remaining cases of genetic deafness, with more than 300 syndromes described.[2] Some syndromes have a particular inheritance pattern (eg, AD for Waardenburg syndrome and Gernet syndrome, AR for Jervell Lange-Nielson syndrome and Winter syndrome, X linked for Alport syndrome and Rosenberg syndrome). Others are sporadic (eg, cat-eye syndrome, Turner syndrome, Klinefelter syndrome). Physical findings usually help to indicate the presence of a particular syndrome; however, children with some syndromes develop the associated physical findings late in childhood. Other children present early in life with either deafness or the sequelae of a biochemical or metabolic derangement.

As noted above, syndromes may affect any single organ or several organ systems. Just as the genetics of nonsyndromic deafness have advanced, more is known about the genetics of syndromes associated with deafness. For example, Waardenburg syndrome type IV is caused by an abnormality of endothelin 3 (EDN3), which results in abnormalities of ligand molecules affecting striatal intermediate, GI, and pigment cells.[22]

Syndromic associations

A small sample of syndromes associated with deafness is summarized below. A few may be familiar, although many are not; most are fairly uncommon. For many of these syndromes, good data about their actual prevalences are difficult to find.

The first few syndromes listed for each organ or system are most commonly known. They may be most widely recognized because their associated findings or illnesses may result in high morbidity or mortality rates, because the physical stigmata are classic and therefore make the syndrome easily identifiable, or because they are overrepresented in test questions on pediatric examinations.

Table. Some Syndromes Associated with Deafness (Open Table in a new window)

Organ or SystemSyndromeInheritance PatternHearing LossObvious Physical Abnormalities
External earDiGeorge sequelaeSporadicCHLYes
Branchio-oto-facial syndromeADCHLYes
Townes-Brocks syndromeADSNHLYes
Miller syndromeARCHLYes
Bixler syndromeARCHLYes
CardiacColoboma, heart disease, atresia choanae, retarded growth, and ear anomalies (CHARGE) syndromeAD, AR, X linked, sporadicSNHL, mixedYes
Jervell Lange-Nielson syndromeARSNHLNo
Limb-oto-cardiac syndromeARCHLYes
RenalAlport syndromeAD, AR, X linkedSNHLYes or no
Branchio-oto-renal syndromeADSNHL, CHLYes
Kearns-Sayre syndromeSporadicSNHLYes
Epstein syndromeADSNHLNo
Barakat syndromeARSNHLNo
Mental (retardation)Noonan syndromeSporadicSNHLYes
Killian/Teschler-Nicola syndromeSporadicSNHLYes
Cockayne syndrome, type IARSNHLYes
Gustavson syndromeX linkedSNHLYes
DermatologicWaardenburg syndromeADSNHLYes
Lentigines, ECG, ocular, pulmonary, abnormal, retardation, and deafness (LEOPARD) syndromeADSNHLYes
Senter syndromeARSNHLYes
Black locks with albinism and deafness (BADS) syndromeARSNHLYes
Davenport syndromeARSNHLYes
Endocrine and/or metabolicPendred syndromeARSNHLYes or no
Johanson-Blizzard syndromeARSNHLYes
Refetoff syndromeARSNHLYes
Wolfram syndromeARSNHLYes or no
Kallmann syndromeAD, AR, X linkedSNHL, mixedYes or no
FacialGoldenhar syndromeAD, ARCHL, SNHLYes
Frontometaphyseal dysplasiaX linkedMixedYes
Escher-Hirt syndromeADCHLYes
Levy-Hollister syndromeADSNHLYes
OphthalmologicUsher syndromeARSNHLYes or no
Marshall syndromeADSNHLYes
Alström syndromeARSNHLYes
Harboyan syndromeARSNHLYes or no
Fraser syndromeARCHLYes
Jensen syndromeX linkedSNHLNo
OrthopedicKlippel-Feil sequelaeSporadicCHL, SNHLYes
Stickler syndromeADCHL, SNHL, mixedYes
Craniometaphyseal dysplasiaAD, ARCDYes
Oto-spondylo-megaepiphyseal dysplasia (OSMED) syndromeARSNHLYes

Prenatal causes

Prenatal causes lead to 5-10% of hearing losses. Congenital infections (eg, cytomegaloviral [CMV] infections, herpes, rubella, syphilis, toxoplasmosis, varicella) can result in SNHL.[23] Fetal exposure to teratogens (eg, methyl mercury, retinoic acid, thalidomide, trimethadione) may also result in SNHL. Most of these perinatal insults result in physical abnormalities, which should prompt the clinician to recognize the diagnosis and perform a confirmatory evaluation.

However, the physical findings sometimes are subtle or are not apparent until the child ages (eg Hutchinson molars). In these cases, it may be the identification of hearing loss that leads to the evaluation leading to the diagnosis, or even the later appearance of developmental delays. Even if children with a known prenatal exposure pass the neonatal screen, careful follow-up of their hearing is necessary.

Perinatal causes

Perinatal causes are responsible for 5-15% of hearing losses. A history of prematurity, low birth weight, anoxia and/or low Apgar scores, hyperbilirubinemia, or sepsis should prompt an evaluation of hearing because these conditions may also result in SNHL.

Postnatal causes

About 10-20% of hearing loses are due to postnatal causes. Childhood infections, such as meningitis or mumps, may result in SNHL. Treatment with ototoxic medications, such as aminoglycosides or furosemide, also can lead to SNHL. Otitis media or major head injury may cause SNHL or CHL.

Unknown causes

About 20-30% of deaf children have no certain etiology. Their hearing losses likely result from a maldevelopment of the ear or neurologic system. Such an event may have been a developmental accident or the result of an undiagnosed infection or exposure to a teratogenic agent. However, many are likely due to an undiagnosed genetic defect that may represent a new mutation or a genetic recessive trait.

Previous
 
 
Contributor Information and Disclosures
Author

Rahul K Shah  MD, FACS, FAAP, Associate Professor of Otolaryngology and Pediatrics, Medical Director, Peri-operative Services, Children's National Medical Center, George Washington University School of Medicine and Health Sciences; Attending Physician, Department of Otolaryngology, Children's National Medical Center

Rahul K Shah is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American College of Medical Quality, American College of Physician Executives, American College of Surgeons, Massachusetts Medical Society, Phi Beta Kappa, and Triological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Michael Lotke, MD  Pediatric Clinical Educator, Mount Sinai Hospital–Chicago/Sinai Children's Hospital; Assistant Professor, Department of Pediatrics, Rosalind Franklin University of Medicine and Science

Michael Lotke, MD is a member of the following medical societies: American Academy of Pediatrics and American Public Health Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Orval Brown, MD  Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

John E McClay, MD  Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Glenn C Isaacson, MD, FACS, FAAP  Professor of Otolaryngology-Head and Neck Surgery and Pediatrics, Temple University School of Medicine

Glenn C Isaacson, MD, FACS, FAAP is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society of Pediatric Otolaryngology, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Covidien Honoraria Consulting

References
  1. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci. 1991;630:16-31. [Medline].

  2. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics. Feb 1999;103(2):527-30. [Medline].

  3. Johnson JL, White KR, Widen JE, et al. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol. Pediatrics. Sep 2005;116(3):663-72. [Medline].

  4. Katbamna B, Crumpton T, Patel DR. Hearing impairment in children. Pediatr Clin North Am. Oct 2008;55(5):1175-88, ix. [Medline].

  5. Kenna MA. Neonatal hearing screening. Pediatr Clin North Am. Apr 2003;50(2):301-13. [Medline].

  6. Kerschner JE. Neonatal hearing screening: to do or not to do. Pediatr Clin North Am. Jun 2004;51(3):725-36, x. [Medline].

  7. Berg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE. Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics. Oct 2005;116(4):933-8. [Medline].

  8. Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics. Mar 1999;103(3):546-50. [Medline].

  9. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2000;106(4):798-817. [Medline].

  10. American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2007;120(4):898-921. [Medline].

  11. US Preventive Services Task Force. Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Pediatrics. Jul 2008;122(1):143-8. [Medline].

  12. Nelson HD, Bougatsos C, Nygren P. Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Pediatrics. Jul 2008;122(1):e266-76. [Medline].

  13. Kennedy CR, McCann DC, Campbell MJ, et al. Language ability after early detection of permanent childhood hearing impairment. N Engl J Med. May 18 2006;354(20):2131-41. [Medline].

  14. Roizen NJ. Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am. Feb 1999;46(1):49-64, x. [Medline].

  15. Shargorodsky J, Curhan SG, Curhan GC, Eavey R. Change in prevalence of hearing loss in US adolescents. JAMA. Aug 18 2010;304(7):772-8. [Medline].

  16. McGee J, Walsh EJ. Cochlear Transduction and the Molecular Basis of Auditory Pathology. In: Cummings Otolaryngology: Head & Neck Surgery. 5th ed. St. Louis, Mo: Mosby; 2010:Chapter 146.

  17. Harrison M, Roush J, Wallace J. Trends in age of identification and intervention in infants with hearing loss. Ear Hear. Feb 2003;24(1):89-95. [Medline].

  18. Hildebrand MS, Husein M, Smith RJH. Cochlear Genetic Sensorineural Hearing Loss. In: Cummings Otolaryngology: Head & Neck Surgery. 5th ed. St. Louis, Mo: Mosby; 2010:Chapter 147.

  19. Marlin S, Garabédian EN, Roger G, et al. Connexin 26 gene mutations in congenitally deaf children: pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg. Aug 2001;127(8):927-33. [Medline].

  20. Tashiro K, Konishi H, Sano E, Nabeshi H, Yamauchi E, Taniguchi H. Suppression of the ligand-mediated down-regulation of epidermal growth factor receptor by Ymer, a novel tyrosine-phosphorylated and ubiquitinated protein. J Biol Chem. Aug 25 2006;281(34):24612-22. [Medline].

  21. Modamio-Hoybjor S, Mencia A, Goodyear R, et al. A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss. Am J Hum Genet. Jun 2007;80(6):1076-89. [Medline]. [Full Text].

  22. Bondurand N, Pingault V, Goerich DE, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet. Aug 12 2000;9(13):1907-17. [Medline].

  23. Richardson SO. The child with "delayed speech". Contemp Pediatr. 1992;9(9):55.

  24. Smith RJ, Hone S. Genetic screening for deafness. Pediatr Clin North Am. Apr 2003;50(2):315-29. [Medline].

  25. Genetic Evaluation of Congenital Hearing Loss Expert Panel. Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet Med. May-Jun 2002;4(3):162-71. [Medline].

  26. Choung YH, Moon SK, Park HJ. Functional study of GJB2 in hereditary hearing loss. Laryngoscope. Sep 2002;112(9):1667-71. [Medline].

  27. Gasparini P, Rabionet R, Barbujani G, et al. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet. Jan 2000;8(1):19-23. [Medline].

  28. Green GE, Scott DA, McDonald JM, Woodworth GG, Sheffield VC, Smith RJ. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA. Jun 16 1999;281(23):2211-6. [Medline].

  29. Parry DA, Booth T, Roland PS. Advantages of magnetic resonance imaging over computed tomography in preoperative evaluation of pediatric cochlear implant candidates. Otol Neurotol. Sep 2005;26(5):976-82. [Medline].

  30. [Guideline] Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2007;120(4):898-921. [Medline].

  31. Berlin CI, Morlet T, Hood LJ. Auditory neuropathy/dyssynchrony: its diagnosis and management. Pediatr Clin North Am. Apr 2003;50(2):331-40, vii-viii. [Medline].

  32. Brookhouser PE, Beauchaine KL, Osberger MJ. Management of the child with sensorineural hearing loss. Medical, surgical, hearing aids, cochlear implants. Pediatr Clin North Am. Feb 1999;46(1):121-41. [Medline].

  33. American Academy of Pediatrics Joint Committee on Infant Hearing. Joint Committee on Infant Hearing 1994 Position Statement. Pediatrics. Jan 1995;95(1):152-6. [Medline].

  34. Horn RM, Nozza RJ, Dolitsky JN. Audiological and medical considerations for children with cochlear implants. Am Ann Deaf. Apr 1991;136(2):82-6. [Medline].

Previous
Next
 
Cochlear malformations. Neural foramen on the right is absent. Right arrow indicates a rudimentary vestibule. On the left is a severe cochlear malformation (large arrow). Small arrow indicates the internal auditory canal.
Cochlear implant electrode passing through the facial recess to the scala tympani.
Table. Some Syndromes Associated with Deafness
Organ or SystemSyndromeInheritance PatternHearing LossObvious Physical Abnormalities
External earDiGeorge sequelaeSporadicCHLYes
Branchio-oto-facial syndromeADCHLYes
Townes-Brocks syndromeADSNHLYes
Miller syndromeARCHLYes
Bixler syndromeARCHLYes
CardiacColoboma, heart disease, atresia choanae, retarded growth, and ear anomalies (CHARGE) syndromeAD, AR, X linked, sporadicSNHL, mixedYes
Jervell Lange-Nielson syndromeARSNHLNo
Limb-oto-cardiac syndromeARCHLYes
RenalAlport syndromeAD, AR, X linkedSNHLYes or no
Branchio-oto-renal syndromeADSNHL, CHLYes
Kearns-Sayre syndromeSporadicSNHLYes
Epstein syndromeADSNHLNo
Barakat syndromeARSNHLNo
Mental (retardation)Noonan syndromeSporadicSNHLYes
Killian/Teschler-Nicola syndromeSporadicSNHLYes
Cockayne syndrome, type IARSNHLYes
Gustavson syndromeX linkedSNHLYes
DermatologicWaardenburg syndromeADSNHLYes
Lentigines, ECG, ocular, pulmonary, abnormal, retardation, and deafness (LEOPARD) syndromeADSNHLYes
Senter syndromeARSNHLYes
Black locks with albinism and deafness (BADS) syndromeARSNHLYes
Davenport syndromeARSNHLYes
Endocrine and/or metabolicPendred syndromeARSNHLYes or no
Johanson-Blizzard syndromeARSNHLYes
Refetoff syndromeARSNHLYes
Wolfram syndromeARSNHLYes or no
Kallmann syndromeAD, AR, X linkedSNHL, mixedYes or no
FacialGoldenhar syndromeAD, ARCHL, SNHLYes
Frontometaphyseal dysplasiaX linkedMixedYes
Escher-Hirt syndromeADCHLYes
Levy-Hollister syndromeADSNHLYes
OphthalmologicUsher syndromeARSNHLYes or no
Marshall syndromeADSNHLYes
Alström syndromeARSNHLYes
Harboyan syndromeARSNHLYes or no
Fraser syndromeARCHLYes
Jensen syndromeX linkedSNHLNo
OrthopedicKlippel-Feil sequelaeSporadicCHL, SNHLYes
Stickler syndromeADCHL, SNHL, mixedYes
Craniometaphyseal dysplasiaAD, ARCDYes
Oto-spondylo-megaepiphyseal dysplasia (OSMED) syndromeARSNHLYes
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.